A new took developed by MIT researchers uses neural networks to help identify Covid-19, reports Alyse Stanley for Gizmodo. The model “can detect the subtle changes in a person’s cough that indicate whether they’re infected, even if they don’t have any other symptoms,” Stanley explains.
TechCrunch reporter Devin Coldewey writes that MIT researchers have built a new AI model that can help detect Covid-19 by listening to the sound of a person’s cough. “The tool is detecting features that allow it to discriminate the subjects that have COVID from the ones that don’t,” explains Brian Subirana, a research scientist in MIT’s Auto-ID Laboratory.
MIT researchers have developed a new AI model that could help identify people with asymptomatic Covid-19 based on the sound of their cough, reports CBS Boston. The researchers hope that in the future the model could be used to help create an app that serves as a “noninvasive prescreening tool to figure out who is likely to have the coronavirus.”
Biobot Analytics, an MIT startup, is testing sewage in regions across the U.S. as part of an effort to detect where the coronavirus is circulating “even before people start showing up at hospitals and clinics and before they start lining up for Covid-19 tests,” writes Maggie fox for CNN.
The Association for the Advancement of Artificial Intelligence has awarded Prof. Regina Barzilay a $1 million prize for her work advancing the use of AI in medicine, reports John McCormick for The Wall Street Journal. "Regina is brilliant, has very high standards, and is committed to helping others,” says Prof. James Collins. “And I think her experience with—her personal experience with cancer—has motivated her to apply her intellectual talents to using AI to advance health care.”
The AP highlights how Prof. Regina Barzilay has been named the inaugural winner of a new award given by the Association for the Advancement of Artificial Intelligence for her work “using computer science to detect cancer and discover new drugs has won a new $1 million award for artificial intelligence.”
Prof. Regina Barzilay has been named the inaugural recipient of the Squirrel AI Award for Artificial Intelligence to Benefit Humanity for her work developing new AI techniques to help improve health care, reports Rebecca Robbins for STAT. Robbins writes that Barzilay is focused on turning the “abundance of research on AI in health care into tools that can improve care.”
Tech Explorist reporter Amit Malewar writes that researchers from Singapore-MIT Alliance for Research and Technology (SMART) have “demonstrated a new way to manufacture human red blood cells (RBCs) that cuts the culture time by half compared to existing methods.”
A CRISPR-based diagnostic test for Covid-19 developed by researchers from MIT and the Broad Institute could produce results within an hour, reports Deborah Becker for WBUR. "Using these technologies will really allow for much more rapid testing — down from days to sometimes less than an hour," said McGovern fellow Jonathan Gootenberg. "That would enable a drastic change in how the tracing and handling of the pandemic is done."
A new center established at the McGovern Institute for Brain Research is aimed at accelerating the development of novel therapies and technologies, writes Katie Jennings for Forbes. The hope is that “we can identify common pathways, either a common molecular pathway that's a chokepoint for a therapy or a common group of neurons or neural systems,” says Prof. Robert DeSimone, director of the McGovern Institute.
Boston Globe reporter Felice Freyer writes about the K. Lisa Yang and Hock E. Tan Center for Molecular Therapeutics in Neuroscience, which was established at the McGovern Institute for Brain Research thanks to a $28 million gift from philanthropist Lisa Yang and MIT alumnus Hock Tan ’75. “The center will develop tools to precisely target the malfunctioning genes and neurons underpinning brain disorders,” writes Freyer.
Fast Company reporter Adele Peters spotlights how, as part of an effort to reduce Covid-19 risk for health care workers, researchers from MIT and Brigham and Women’s Hospital developed a new system that enables remote vital sign monitoring. "We started to think about how we could protect healthcare providers and minimize contact with folks that might be infectious,” says Prof. Giovanni Traverso.
CNN reporter Allen Kim spotlights how researchers from MIT and Brigham and Women’s Hospital have modified a robotic dog so that it can be used to help measure a patient’s vital signs. “The researchers expect to focus on triage applications in the short term, with the goal of ultimately deploying robots like this to patients' hospital rooms to continuously monitor them and let doctors to check in on them without ever having to step into the room,” writes Kim.
CBS Boston features how researchers from MIT and Brigham and Women’s Hospital equipped a robot from Boston Dynamics with technology to enable remote vital sign monitoring.
In this video, Bloomberg News spotlights how researchers from MIT and Brigham and Women’s Hospital have developed a new system that facilitates remote monitoring of a patient’s vital signs, as part of an effort to help reduce healthcare workers’ Covid-19 risk. Researchers have successfully measured temperature, breathing rate, pulse rate and blood oxygen saturation in healthy patients.”